(S (NP-SBJ (JJ Retinoic) (NN acid)) (VP (VBZ activates) (NP (NP (NN interferon) (JJ regulatory) (JJ factor-1) (NN gene) (NN expression)) (PP (IN in) (NP (JJ myeloid) (NNS cells))))) (. .))
(S (NP-SBJ (NP (JJ All-trans-retinoic) (NN acid)) (PRN (-LRB- -LRB-) (NP (NN ATRA)) (-RRB- -RRB-))) (VP (VBZ is) (NP-PRD (NP (DT the) (NN drug)) (PP (IN of) (NP (NN choice)))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (JJ acute) (JJ promyelocytic) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN APL)) (-RRB- -RRB-))))))) (. .))
(S (NP-SBJ (NN ATRA)) (VP (VBZ induces) (NP (NP (NP (ADJP-COOD (CC both) (ADJP (FW in) (FW vitro)) (CC and) (ADJP (FW in) (FW vivo))) (NN differentiation)) (PP (IN of) (NP (NN APL) (NNS cells)))) (PP (IN into) (NP (JJ mature) (NNS granulocytes))))) (. .))
(S (ADVP (RB However)) (, ,) (NP-SBJ-63 (NP (DT the) (JJ molecular) (NNS mechanisms)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (JJ ATRA-dependent) (NP-COOD (NP (NN growth) (NN inhibition)) (CC and) (NP (JJ cellular) (NN differentiation))))))) (VP (VBP are) (RB not) (ADVP-TMP (RB presently)) (VP (VBN understood) (NP (-NONE- *-63)))) (. .))
(S (NP-SBJ-64 (NP (DT The) (NN NB4) (NN cell) (NN line)) (, ,) (SBAR (WHNP-65 (WDT which)) (S (NP-SBJ-66 (-NONE- *T*-65)) (VP (VBZ is) (VP (VBN derived) (NP (-NONE- *-66)) (PP (IN from) (NP (NP (DT the) (NN bone) (NN marrow)) (PP (IN of) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NN APL))))))) (PP-TMP (IN during) (NP (NN relapse))))))) (, ,)) (VP (MD can) (VP (VB be) (VP (VBN used) (NP (-NONE- *-64)) (PP (IN as) (NP (NP (DT a) (JJ model) (NN system)) (SBAR (WHADVP-106 (-NONE- 0)) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB study) (NP (NP (DT the) (NP-COOD (NP (NN growth)) (CC and) (NP (NN differentiation)))) (PP (IN of) (NP (NN APL) (NNS cells)))) (ADVP (-NONE- *T*-106))))))))))) (. .))
(S (SBAR (IN Because) (S (NP-SBJ-COOD (NP (NP (NP (NP (NN interferon)) (PRN (-LRB- -LRB-) (NP (NN IFN)) (-RRB- -RRB-))) (JJ regulatory) (NNS factors)) (PRN (-LRB- -LRB-) (NP-COOD (NP (NN IRF-1)) (CC and) (NP (NN IRF-2))) (-RRB- -RRB-))) (CC and) (NP (JJ other) (JJ IFN-inducible) (NN gene) (NNS products))) (VP (VBP regulate) (NP (NN cell) (NN growth))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD analyzed) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN ATRA))) (PP (IN on) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT these) (NNS genes))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ (NN ATRA)) (ADVP (RB directly)) (VP (VBZ activates) (NP (NN IRF-1) (NN gene) (NN expression)) (, ,) (S (NP-SBJ-68 (-NONE- *)) (VP (VBN followed) (NP (-NONE- *-68)) (PP (IN by) (NP-LGS (NP (NN activation)) (PP (IN of) (NP (NP-COOD (NP (NN IRF-2)) (CC and) (NP (JJ 2'-5') (NP (NP (NN oligoadenylate) (NN synthetase)) (PRN (-LRB- -LRB-) (NP (NN OAS)) (-RRB- -RRB-))))) (NN gene) (NN expression))) (PP (IN with) (NP (JJR slower) (NNS kinetics))))))))))) (. .))
(S (PP (IN In) (NN addition) (TO to) (NP (NN NB4) (NNS cells))) (, ,) (NP-SBJ (NN ATRA)) (ADVP (RB also)) (VP (VBD activated) (NP (NP (NN IRF-1) (NN gene) (NN expression)) (PP (IN in) (NP (NP (NP-COOD (NP (NN HL-60)) (, ,) (NP (NN U937)) (, ,) (CC and) (NP (NN THP-1))) (NNS cells)) (, ,) (SBAR (WHNP-69 (WDT which)) (S (NP-SBJ (NP (-NONE- *T*-69)) (NP (DT all))) (VP (VBP respond) (PP (TO to) (NP (NN ATRA))) (PP (IN by) (NP (NN growth) (NN inhibition)))))))))) (. .))
(S (NP-SBJ-70 (NP (DT A) (ADJP (ADJP (JJR more)) (PP (IN than) (ADJP (JJ additive)))) (NN increase)) (PP (IN in) (NP (NN IRF-1) (NN gene) (NN expression)))) (VP (VBD was) (VP (VBN seen) (NP (-NONE- *-70)) (PP (IN with) (NP-COOD (NP (NN ATRA)) (CC and) (NP (NN IFN-gamma)))) (PP (IN in) (NP (NN NB4) (NNS cells))))) (. .))
(S (NP-SBJ (NN ATRA)) (VP (VBD did) (RB not) (VP (VB activate) (NP-COOD (NP (JJ nuclear) (NN factor) (NN kappa) (NN B)) (CC or) (NP (NP (NP (NP-COOD (NP (NN signal) (NN transducer)) (CC and) (NP (NN activator))) (PP (IN of) (NP (NN transcription)))) (PRN (-LRB- -LRB-) (NP (NN STAT)) (-RRB- -RRB-))) (NN activation) (NNS pathways))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ-72 (DT an) (JJ alternate) (NN mechanism)) (VP (VBZ is) (VP (VBN involved) (NP (-NONE- *-72)) (PP (IN in) (NP (NN IRF-1) (NN gene) (NN activation))))))))))) (. .))
(S (NP-SBJ (NP (DT The) (JJ ATRA-induced) (NN expression)) (PP (IN of) (NP (NP (NN IRF-1)) (, ,) (NP (DT an) (NP-COOD (NP (NP (NN activator)) (PP (IN of) (NP (NN transcription)))) (CC and) (NP (NP (NN repressor)) (PP (IN of) (NP (NN transformation)))))) (, ,)))) (VP (MD may) (VP (VB be) (NP-PRD-COOD (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ molecular) (NNS mechanisms)) (PP (IN of) (NP (JJ ATRA-induced) (NN growth) (NN inhibition)))))) (, ,) (CC and) (NP (NP (DT the) (NN basis)) (PP (IN for) (NP (NP (DT the) (JJ synergistic) (NNS actions)) (PP (IN of) (NP-COOD (NP (NN ATRA)) (CC and) (NP (NN IFNs)))) (PP (IN in) (NP (JJ myeloid) (NN leukemia) (NNS cells))))))))) (. .))
